In all, participants who received tirzepatide Eli Lillys (NYSE:LLY) tirzepatide achieved up to 15.7% weight loss in the SURMOUNT-2 study, sparking a potential tirzepatide versus semaglutide competition in the obesity and type 2 diabetes treatment markets
Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM
In the 1990s, investigators learned that Gila monsters a venomous lizard produced a hormone similar to GLP-1
What was initially prescribed as a diabetic drug has morphed into a weight loss drugand promises to address other chronic health conditions
No significant differences were observed on the social cognition and communication SRS subscales
Testing scope Whether third-party testing applies to the entire blended product , rather than only to individual peptide components